The face of postural tachycardia syndrome – insights from a large cross‐sectional online community‐based survey

• DOI: 10.1111/joim.12895
• Publication Date: 2019-03-12T17:58:22Z
• Authors: B. H. Shaw; L. E. Stiles; K. Bourne; E. A. Green; C. A. Shibao; L. E. Okamoto; E. M. Garland; A. Gamboa; A. Diedrich; V. Raj; R. S. Sheldon; I. Biaggioni; D. Robertson; S. R. Raj
• Keywords: Adult; Male; Original Articles; Middle Aged; 3. Good health; Postural Orthostatic Tachycardia Syndrome; 03 medical and health sciences; Cross-Sectional Studies; 0302 clinical medicine; Surveys and Questionnaires; Humans; Female; Aged

AbstractBackgroundPatients with postural tachycardia syndrome (POTS) experience chronic symptoms of orthostatic intolerance. There are minimal data detailing the demographics, clinical features and clinical course of this condition. This online, community‐based survey highlights patients’ experience with POTS. It consists of the largest sample of POTS patients reported to date.ObjectivesTo describe the demographics, past medical history, medications, treatments and diagnostic journey for patients living with POTS.MethodsPostural tachycardia syndrome patients completed an online, community‐based, cross‐sectional survey. Participants were excluded if they had not received a diagnosis of POTS from a physician. The questions focused on the patient experience and journey, rather than physiological responses.ResultsThe final analysis included 4835 participants. POTS predominantly affects white (93%) females (94%) of childbearing age, with approximately half developing symptoms in adolescence (mode 14 years). POTS is a chronic multisystem disorder involving a broad array of symptoms, with many patients diagnosed with comorbidities in addition to POTS. POTS patients often experience lengthy delays [median (interquartile range) 24 (6–72) months] and misdiagnosis, but the diagnostic delay is improving. POTS patients can present with a myriad of symptoms most commonly including lightheadedness (99%), tachycardia (97%), presyncope (94%), headache (94%) and difficulty concentrating (94%).ConclusionsThese data provide important insights into the background, clinical features and diagnostic journey of patients suffering from POTS. These data should serve as an essential step for moving forward with future studies aimed at early and accurate diagnoses of these patients leading to appropriate treatments for their symptoms.